NASDAQ · Drug Manufacturers - Specialty & Generic

LNTH (LNTH) Stock

$108.03 +3.06% NASDAQ: LNTH Healthcare

Valuation

MetricValue
Price$108.03
Market Cap$7.03B
P/E Ratio27.24
P/B Ratio5.55
P/S Ratio3.91
EPS (TTM)$3.41
52-Week High$111.46
52-Week Low$47.25
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE21.47%
ROA10.51%
ROCE28.56%
Gross Margin20.17%
Operating Margin20.17%
Net Margin18.05%
Debt/Equity0.00
Current Ratio2.70

Annual Financials (USD)

Metric20212022202320242025
Revenue$425.0M$935.0M$1.3B$1.5B$1.5B
Operating Profit$-61.0M$36.0M$365.0M$457.0M$311.0M
Net Profit$-71.0M$28.0M$327.0M$312.0M$234.0M
EPS$-1.06$0.40$4.65$4.36$3.41
Op Margin-14.3%3.9%28.1%29.8%20.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$864.0M$1.3B$1.7B$2.0B$2.2B
Total Liabilities$399.0M$874.0M$835.0M$892.0M$1.1B
Cash$99.0M$416.0M$714.0M$913.0M$359.0M
Borrowings$191.0M$584.0M$617.0M$619.0M$1.0M

Latest News

RadioMedix Appoints Brian A. Markison to Board of Directors GlobeNewswire · Jul 15, 2026 LNTH: Lowering target price to $107.00 Argus Research · Jul 15, 2026 3 Reasons to Avoid LNTH and 1 Stock to Buy Instead StockStory · Jul 14, 2026 1 Small-Cap Stock with Competitive Advantages and 2 We Brush Off StockStory · Jul 13, 2026 B. Riley Adjusts Price Target on Lantheus Holdings to $129 From $97, Maintains Buy Rating MT Newswires · Jul 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$54.0M$282.0M$305.0M$545.0M$390.0M
Investing Cash Flow$-8.0M$-295.0M$-41.0M$-278.0M$-663.0M
Financing Cash Flow$3.0M$-72.0M$-14.0M$-122.0M$-326.0M
Net Cash Flow$18.0M$317.0M$298.0M$199.0M$-554.0M
Free Cash Flow$42.0M$263.0M$259.0M$493.0M$354.0M

Valuation & Return Ratios

MetricValue
PEG Ratio
EV / EBITDA14.93
FCF Yield6.15%
Quick Ratio2.64
Interest Coverage15.55
Return 1Y50.85%
Return 3Y23.32%
Return 5Y321.35%

Ownership

Insiders Held2.09%
Institutions Held116.40%
Institutions Float Held118.88%
Institutional HolderSharesReport Date
Blackrock Inc.8,183,1932026-03-31
Farallon Capital Management LLC5,583,4792026-03-31
Janus Henderson Group PLC4,774,8412026-03-31
FMR, LLC4,626,4532026-03-31
Vanguard Portfolio Management LLC3,174,2742026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACAD $29.21 +2.67% 8.94 $5.00B 0.00%
ADMA $8.71 -0.91% 12.17 $2.02B 0.00%
AMRXAmneal Pharmaceuticals, Inc. $18.01 +0.47% 47.29 $5.75B 0.00%
BHCBausch Health Companies Inc. $4.58 +3.27% -1.38 $1.71B 0.00%
CRNX $83.81 -0.09% -8.57 $8.87B 0.00%

About LNTH

LNTH is led by CEO Mary Anne Heino, employs 1,193 people, headquartered in Bedford, US, publicly traded since 2015.

LNTH stock trades at $108.03 with a market capitalization of $7.03B. The stock is valued at a price-to-earnings (P/E) ratio of 27.24, price-to-book of 5.55, price-to-sales of 3.91. Over the past 52 weeks the stock has ranged between $47.25 and $111.46, and currently trades 3.1% below its 52-week high.

On profitability, LNTH generates a return on equity (ROE) of 21.47% — well above the market average, a sign of a high-quality business, return on capital employed of 28.56%, an operating margin of 20.17%, a net profit margin of 18.05%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides